Recently, Grand Shuyang Life Sciences (Chengdu) Co., Ltd. officially passed the Capability Maturity Model for Intelligent Manufacturing (CMMM) Level 3 (Integrated Level) certification.

About CMMM Certification

The Maturity Model of Intelligent Manufacturing Capability (GB/T 39116-2020) and Maturity Assessment Method of Intelligent Manufacturing Capability (GB\T 39117-2020) are national intelligent manufacturing assessment systems introduced by the China Electronics Standardization Institute, classifying intelligent manufacturing capability into five levels. Level 3 (Integrated Level) mandates that enterprises enable cross-business data sharing and system integration across production, logistics, quality, and other key links, thus breaking down information silos and fostering an interconnected digital manufacturing capability.

Dual Authoritative Recognition, Signifying A Systematic Leap in Intelligent Manufacturing

Passing the Level 3 certification signifies that Grand Shuyang has effectively integrated its key business systems with production data, shifting business links from isolated silos to an integrated framework. The company now possesses a comprehensive, data-driven capability to enable production control, quality assurance, and operational decision-making.

Previously, Grand Shuyang was recognized as a 2023 Outstanding Intelligent Manufacturing Scenario by the Ministry of Industry and Information Technology of China and as an Advanced Intelligent Factory by Sichuan Province. Achieving CMMM Level 3 certification has secured dual authoritative recognition for the company, namely "Advanced Factory Construction Achievements" and "Intelligent Manufacturing Maturity Capability". Together, they demonstrate that the company's intelligent manufacturing has evolved from isolated systems or local scenarios to a systematic capability that covers every key link in production and operations.

Looking Forward: Empowering Life and Health through Intelligent Manufacturing

Looking ahead, Grand Shuyang remains steadfast in its commitment to quality improvement and value creation. The company plans to steadily refine its intelligent manufacturing system, deepen the innovative application of new technologies (AI, data analysis, etc.) in scenarios like quality testing, predictive maintenance, intelligent production scheduling, energy management, and operations management. By driving industrial upgrading through technological innovation, the company will pioneer new pathways for the deep integration between life science manufacturing and digital technologies. With a safer, more reliable, more efficient, and more intelligent manufacturing capability, the company aims to secure a stable supply of high-quality blood products and make greater contributions to the high-quality development of the life and health industry.